Pridopidine Phase 3 Study in Huntington's Disease

Clinical trial NCT07609108 · RECRUITING

Trial details

NCT number: NCT07609108
Sponsor: Prilenia
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Huntington Disease

Start date: 2026-07-01
Primary completion: 2028-06-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.